Med BioGene Inc (MBI) - Medical Equipment - Deals and Alliances Profile

Summary

Med BioGene Inc (Med BioGene) is a life sciences company, which develops and commercializes genome-based clinical laboratory diagnostic tests. The companys lead test under development, GeneFx Lung formerly LungExpress Dx, is a proprietary gene expression based test. Its GeneFx Lung test is used to identify patients with early-stage non-small-cell lung cancer (NSCLC) and determine whether they are at higher or lower risk of mortality following the surgical removal of their tumor. The GeneFx Lung test is also expected to provide informed and personalized treatment decisions that assist in selecting the patients for adjuvant chemotherapy. Med BioGene is headquartered in Vancouver, British Columbia, Canada.

Med BioGene Inc (MBI) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Med BioGene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Med BioGene Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Med BioGene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Med BioGene Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Med BioGene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Med BioGene Inc, Medical Equipment, Deal Details 10
Partnerships 10
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 10
Respira Health Announces Licensing Agreement With Med BioGene 12
Equity Offering 1
Med BioGene to Raise USD0.2 Million in Private Placement of Units 1
Med BioGene Completes Private Placement Of US$0.22 Million 14
Med BioGene Inc - Key Competitors 15
Med BioGene Inc - Key Employees 16
Med BioGene Inc - Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List Of Tables

List of Tables
Med BioGene Inc, Medical Equipment, Key Facts, 2016 2
Med BioGene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Med BioGene Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Med BioGene Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Med BioGene Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Med BioGene Inc, Deals By Market, 2011 to YTD 2017 8
Med BioGene Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Med BioGene Enters Into Licensing Agreement With Precision Therapeutics 10
Respira Health Announces Licensing Agreement With Med BioGene 12
Med BioGene to Raise USD0.2 Million in Private Placement of Units 13
Med BioGene Completes Private Placement Of US$0.22 Million 14
Med BioGene Inc, Key Competitors 15
Med BioGene Inc, Key Employees 16
Med BioGene Inc, Subsidiaries 17

Globus Medical Strategic SWOT Analysis Performance Capabilities Goals Strategies

This report is part of the Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the development

USD 950 View Report

Medical Device Market Emerging Trends

2024 Whats Next for Medical Device Market--Emerging Trends, Forecasts, Latest Technologies, Competitive SWOT Analysis This report is part of the Competitive Analysis Series prepared by to help current

USD 4500 View Report

Med BioGene Inc (MBI.H) - Financial and Strategic SWOT Analysis Review

Med BioGene Inc (MBI.H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Med BioGene Inc (MBI) - Financial and Strategic SWOT Analysis Review

Med BioGene Inc (MBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available